Navigation Links
Scripps Research scientist receives $1 million research grant from Novo Nordisk
Date:11/8/2011

JUPITER, FL, November 8, 2011 Andrew Butler, an associate professor in The Scripps Research Institute's Department of Metabolism and Aging, has been awarded one million dollars in funding over the next two years to further his research into a novel protein with the potential to improve the understanding and future treatment of diabetes.

The award is notable in that it comes not from the US National Institutes of Health but from Novo Nordisk, an international healthcare company based in Denmark recognized as a world-leader in diabetes treatment.

The Novo Nordisk Diabetes Innovation Award Program was launched in 2011 to help scientists substantiate early research efforts that could result in new treatment options for diabetes and obesity.

Butler's two-year research project, entitled the "Investigation of a Novel Peptide Hormone in Diabetes Treatment," was selected from more than 80 submitted proposals from US and Canadian research institutions.

The research involves a peptide hormone secreted by the liver called adropin. Animal models have shown that peptide hormones play an important role in regulating glucose levels and fatty acid metabolism and that irregular function of these hormones can have a direct effect on an individual's risk of developing obesity and/or diabetes.

"We were studying animal models of insulin resistance as precursor to type 2 diabetes, when we came across adropin," Butler said. "We found it provocative that this particular peptide hormone was distributed in the brain, liver, and pancreasthree tissues that are of great interest to those of us in the diabetes research field."

Butler noted that adropin seems to play a role in maintaining normal insulin sensitivitywhereby only a relatively small amount of insulin is needed to maintain regular blood glucose levels. In type 2 diabetes, insulin sensitivity is often blunted, which means that the normal amounts of insulin produced by the body are no longer as effective in lowering blood glucose levels.

"What has not been established are the mechanisms and sites of action that effect glucose homeostasis [equilibrium]," he said. "So that's what we're going to spend the next two years finding out with the help of this research grant from Novo Nordisk."

The research will also explore adropin's potential role as a protein-based therapy for treating type 2 diabetes, a chronic disease that affects over 300 million people worldwide, according to the World Health Organization. "Clearly, there is an urgent need to identify new and more effective drugs for treating diabetes," Butler said. "Studying how adropin works in this regard could eventually contribute to this effort."


'/>"/>

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Source:Eurekalert  

Related medicine news :

1. Scripps Florida scientist awarded $2.2 million grant to study hepatitis C
2. Scripps research scientist wins $3.6 million NIH Method to Extend Research in Time award to study alcoholism in Native Americans
3. Scripps Health and Sanford-Burnham to collaborate to advance new cancer treatments
4. Scripps Research scientists reveal how white blood cell promotes growth and spread of cancer
5. Scripps Research scientists define cellular pathway essential to removing damaged mitochondria
6. Scripps Translational Science Institute joins Jackson Laboratory tumor consortium
7. Scripps Research scientists show how shifts in temperature prime immune response
8. CIRM awards Scripps Research Institute scientists $3.5 million
9. Scripps Research wins more than $2 million to study prostate cancer
10. New lupus drug results from Scripps Research technology
11. Scripps Research and MIT scientists discover class of potent anti-cancer compounds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scripps Research scientist receives $1 million research grant from Novo Nordisk
(Date:9/19/2017)... ... September 19, 2017 , ... The Workgroup for Electronic Data ... to create efficiencies in healthcare information exchange and a trusted advisor to the U.S. ... industry white paper, entitled Barriers to Adoption of the ERA and EFT Transactions ...
(Date:9/19/2017)... ... ... Public outrage over the toxins that exist in tap water and the ... industry itself to research, develop and ultimately supply consumers with healthy drinking water alternatives. ... natural alkaline water technologies, water filtration systems, and consumer education. ...
(Date:9/19/2017)... ... September 19, 2017 , ... Bone Solutions Inc. (BSI), ... magnesium-based orthopedic medical device, OsteoCrete®. OsteoCrete® bone void filler is designed to assist ... incorporate magnesium, a critical property for bone health and development. , “We’re excited ...
(Date:9/19/2017)... ... September 19, 2017 , ... Ron Norman, CEO of Team Decades, ... making a distinct rather than generic impression in the job market if one is ... stack of resumes knows that the first impression they give off is not a ...
(Date:9/19/2017)... IL (PRWEB) , ... September 19, 2017 , ... ... significantly and positively linked to the Certified Emergency Nurse (CEN®) certification ... Emergency Nursing (BCEN). The value of certification study, conducted by the Human Resources ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
(Date:9/5/2017)... 2017 Sapheneia and Scannerside received FDA 510(k) ... is a third-party Vendor neutral CT product that makes ... compliance with current MITA standards. ... solution is specifically designed to provide CT operators, prior ... doses over a predefined threshold. Scannerside Dose Check is ...
(Date:9/5/2017)...  Getinge, a leading global provider of innovative ... program -- "Color for the Kids!" -- to ... by The Children,s Heart Foundation. Pediatric patients and ... encouraged to download a coloring picture at ... the gallery on the website. For each artwork ...
Breaking Medicine Technology: